Tapering has no established pharmacologic advantage but may allow the clinician to identify the lowest effective maintenance dose if long-term therapy is the goal
His lawsuit is about accountability ensuring companies put patient safety before corporate profit. The complaint specifically alleges that Novo Nordisk had access to information identifying NAION cases during clinical trials yet chose not to list the condition on warning labels
Who Should Not Use GLP-1 Medications: Provider-Guided Exclusions Absolute contraindications include personal history of medullary thyroid carcinoma or MEN 2 syndrome, severe gallbladder disease, uncontrolled diabetic retinopathy, and acute pancreatitis
In fact, a systematic review aiming to identify factors associated with adherence to insulin therapy in type 1 and type 2 diabetes showed that adherence is generally poor and suggested that more flexible regimen may improve it as well as facilitating insulin deliver by switching to a pen device [14]
As a member of the phenethylamine class, amphetamine is also chemically related to the naturally occurring trace amine neuromodulators, specifically phenethylamine and N -methylphenethylamine, both of which are produced within the human body
In recent months, the company was involved in a legal dispute with Novo Nordisk over the acquisition of Metsera, a biopharmaceutical firm focused on obesity therapies
